UACC-812（人乳腺導管瘤細胞）
CBP60409
詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | UACC-812 |
| Background: | This cell line was established by A. Liebovitz and associates in 1986 from breast tissue removed at mastectomy to remove a ductal carcinoma (stage II, grade IV). |
| Species: | Homo sapiens, human |
| Tissue: | mammary gland; breast |
| Disease: | ductal carcinoma |
| Gender: | female, 43 years |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| Doubling Time: | 100 hrs |
| DNA Profile: | Amelogenin: X CSF1PO: 11 D13S317: 12 D16S539: 8, 11 D5S818: 11, 12 D7S820: 9 THO1: 9 TPOX: 8, 11 vWA: 16 Our Cell Line Authentication Service |
| Culture Medium: |
DMEM+20 ng/ml human EGF+20%FBS UACC-812完全培養(yǎng)基，# CBP60409M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | N/A |
| Receptor Expression: | estrogen receptor (negative), progesterone receptor (negative) |
| Oncogene: | N/A |
| Genes Expressed: | N/A |
| Cellular Products: | N/A |
| Tumor Formation: | N/A |
| Comments: | Prior to surgery, the patient had received extensive chemotherapy. The cells exhibit a 15 fold amplification of the HER-2/neu oncogene sequence. They are negative for estrogen receptors, progesterone receptors and P glycoprotein. For more information, please contact us (4008-750-250). |
